Sterile Injectables Market By Drug Type (Monoclonal Antibodies, Cytokines, Insulin, Immunoglobulin, Vaccines, Peptide Hormones, Peptide Antibiotics, Blood Factors and Others), By Therapeutic Area (Cancer, Infectious Diseases, Diabetes, Cardiovascular Diseases, Neurological Diseases, Musculoskeletal Diseases and Others) - Growth, Future Prospects and Competitive Analysis, 2017 - 2025

Sterile injectables market is rising with growing demand for biologics in order to treat numerous medical conditions with immediate and effective outcomes. Widening application of injectables have transformed medical treatments as higher quality of sterile injectables have lowered chances of risk or any contamination.

Growing prevalence of cancer and chronic diseases contributed to the growth of sterile injectables market. Surging demand for biologics and increasing trend of biosimilars act as major growth factors of sterile injectables market. Expanding usage of generic injectables in pen-filled syringes, pre-filled syringes in medical settings have also boost the market growth. However, low-quality injectables product, inconsistent product launches and recall of substandard products were few reasons behind the global issues of major drug shortage which further caused severe disadvantage to patients and healthcare providers. High cost of automation in product development in order to manufacture improved sterile injectables and stringent regulatory guidelines of product approval have created challenges to the manufacturers which in turn restrain the market growth. Focus on broadened product portfolio with pipeline products and restructuring by mergers and acquisition activities of key players are expected to fuel the future growth of sterile injectables market.

The scope of the research report titled ‘Sterile Injectables Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide investors, company executives, developers and industry experts with detailed analysis of market to take strategic initiatives and business decisions regarding to the prospects of global sterile injectables market. Major market trends prevalent in the global sterile injectables market and the market size of present and forecast periods have been presented in the research report. Global health concern, increasing research expenditure, utilization of advanced technology and product innovation strongly boost the growth of sterile injectables market.

This report contains the global sterile injectables market in terms of drugs type, therapeutic areas and geographical distribution. Based on drug types, the sterile injectables market is segmented into monoclonal antibodies, cytokines, insulin, immunoglobulin, vaccines, peptide hormones, peptide antibiotics, blood factors and others. On the basis of therapeutic areas, the sterile injectables market has been classified as cancer, infectious diseases, diabetes, cardiovascular diseases, neurological diseases, musculoskeletal diseases and others.

On the basis of geography, the sterile injectables market is classified into five major regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa which are further categorized into major country-specific markets. North America region consists of the data for the United States and Canada; whereas the United Kingdom, Germany and rest of Europe have been considered in European region. Asia Pacific encompasses the information for China, Japan, India and rest of Asia Pacific markets. Latin America is cross-sectioned into Brazil, Mexico and other LATAM countries and Middle East and Africa is segmented into GCC, South Africa and other MEA countries. Market size and forecast of every mentioned geography for 2015-2025 along with CAGRs for the forecast period 2017-2025 have been presented in this research report. Furthermore, the considered regional markets are further cross-sectioned on the basis of drug types, and therapeutic areas.

This research study also provides insights in terms of market dynamics factors such as market drivers, restrains and opportunity of present and predicted market of sterile injectables to deploy suitable business strategies. Comprehensive details of competitive assessment tools like partnerships, major agreements, collaborations, mergers and acquisition activities, joint ventures, market attractiveness and competitive landscape analysis by major players are also stated in the report for better understanding purpose. This report comprises of the detailed profiling of few of the major players like Pfizer Inc., Mylan N.V, Baxter International Inc., Novartis AG, AstraZeneca plc., Amgen Limited, Merck & Co., Inc., Johnson & Johnson Services, Inc., Nichi-Iko Pharmaceutical Co., Sanofi, Eli Lilly and Company.

Sterile Injectables Market

 

Geographically, the global sterile injectables market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Sterile Injectables Market

North America is considered to be the leading region in terms of revenue of global sterile injectables market since the U.S. is the main outsourcing destination of sterile injectables. North America is predicted to witness steady growth owing to developed healthcare infrastructure, growing prevalence of cancer, diabetes and emerging health awareness among public. The imbalance in demand-supply equation has affected the sterile injectables market in North America, which has opened penetration opportunity of the manufacturers from other developing countries. The growth opportunity of sterile injectables market in North America is driven by presence of major manufacturers and their market consolidation activities. However, regulatory guidelines and stringent inspection of FDA sometimes act as barriers to new product launch, which in turn restrain the growth of sterile injectables market. The sterile injectables market in Europe is driven by improved product formulation, increasing demand and growing contract manufacturing options.

Asia Pacific is anticipated to witness the fastest growth during upcoming years on the account of developing healthcare infrastructures, emerging economies, and gradual growth in health awareness among public. Market penetration of Western pharmaceuticals manufacturers, changing regulatory guidelines, new product innovation and commercialization, and contract manufacturing are expected to support significant growth of sterile injectables market in Asia Pacific region. Growing interest among Asian manufacturers in terms of manufacturing generic injectables is expected to positively influence global sterile injectables market.

Regional classification of the global sterile injectables market is presented as follows:

  • North America (The United States & Canada)
  • Europe (The United Kingdom, Germany, and rest of European countries)
  • Asia Pacific (India, Japan, China and rest of Asia Pacific countries)
  • Latin America (Mexico, Brazil, and rest of LATAM countries)
  • Middle East and Africa (GCC, South Africa and rest of MEA countries)

The sterile injectables market is categorized on the basis of drug types and the categories are:

·         Monoclonal Antibodies

·         Cytokines

·         Insulin

·         Immunoglobulin

·         Vaccines

·         Peptide Hormones

·         Peptide Antibiotics

·         Blood Factors

·         Other Drugs

The major share of sterile injectables is contributed by monoclonal antibodies, followed by vaccines and insulin owing to increasing awareness among public and growing application areas. The key driver of monoclonal antibody injectables market is increasing prevalence of cancer, respiratory diseases like asthma, infectious diseases and autoimmune diseases like rheumatoid arthritis. Growing demand for monoclonal antibodies is on rise due to proper dosing frequency for any treatment, potential therapeutics and target of specific antigen. Diabetes caused 1.6 million deaths worldwide in the year 2015; such high prevalence of diabetes has increased the market for insulin injectables. Governments and healthcare organizations have taken various initiatives in order to develop improved healthcare system, which drives the growth of sterile injectables market especially vaccine. Injectable vaccines is predicted to witness lucrative growth as a result of development of innovative therapeutic vaccines for disease prevention and their increasing adoption among patients due to offered convenience. Cytokine imbalance causes multiple diseases; therefore injectable cytokine therapy significantly conquer multiple disease progression and therefore influence the growth of the sterile injectables market

Choose License Type
Published Date:  Nov 2017
Category:  Pharmaceuticals
Report ID:   58818
Report Format:   PDF
Pages:   120
Rating:    4.5 (60)
Connect With Us
+1-408-641-3282
24/7 Research Support